Table 1.
Patient characteristics.
| Characteristic | All patients (N = 86) | Moderate (N = 57) | Severe (N = 29) | P-value |
|---|---|---|---|---|
| Age — median (IQR) | 68.5 (59.0–74.8) | 68.0 (57.0–74.0) | 69.0 (63.0–77.0) | 0.20 |
| Race — N (%) | 0.48 | |||
| Caucasian | 38 (44.2) | 23 (40.4) | 15 (51.7) | |
| Black | 39 (45.3) | 26 (45.6) | 13 (44.8) | |
| Asian | 1 (1.2) | 1 (1.8) | 0 (0.0) | |
| Other/Unknown | 8 (9.3) | 7 (12.3) | 1 (3.4) | |
| Hispanic ethnicity — N (%) | 13 (15.1) | 7 (12.3) | 6 (20.7) | 0.48 |
| Smoking history — N (%) | 0.05 | |||
| Never | 58 (67.4) | 43 (75.4) | 15 (51.7) | |
| Former/Current | 28 (32.6) | 14 (24.6) | 14 (48.3) | |
| Number of comorbidities — N (%) | 0.77 | |||
| < 3 | 36 (41.9) | 25 (43.9) | 11 (37.9) | |
| ≥ 3 | 50 (58.1) | 32 (56.1) | 18 (62.1) | |
| Cancer type — N (%) | 0.53 | |||
| Ovary | 26 (30.2) | 16 (28.1) | 10 (34.5) | |
| Uterine | 44 (51.2) | 28 (49.1) | 16 (55.2) | |
| Cervical | 12 (14) | 9 (15.8) | 3 (10.3) | |
| Other | 4 (4.7) | 4 (7.0) | 0 (0.0) | |
| Cancer stage — N (%) | 0.55 | |||
| I/II | 32 (37.2) | 20 (35.1) | 12 (41.4) | |
| III/IV | 40 (46.5) | 26 (45.6) | 14 (48.3) | |
| Unknown | 14 (16.3) | 11 (19.3) | 3 (10.3) | |
| Cancer status — N (%) | 0.77 | |||
| Remission | 36 (41.9) | 25 (43.9) | 11 (37.9) | |
| Evidence of disease | 50 (58.1) | 32 (56.1) | 18 (62.1) | |
| Current cancer treatment — N (%) | 0.77 | |||
| Yes | 39 (45.3) | 27 (47.4) | 12 (41.4) | |
| No | 47 (54.7) | 30 (52.6) | 17 (58.6) | |
| Death due to COVID-19 — N (%) | 25 (29.1) | 0 (0.0) | 25 (86.2) | NA |